Furthermore, the expression of CXCL16 on peripheral monocytes of psoriatic patients correlated significantly with PROCAM (Prospective Cardiovascular Münster Study) score (Figure 1E) that indicates patients’ risk for developing cardiac diseases, such as myocardial infarction or cardiac death in the next 10 years (37). Here, CXCL16 is linked to myocardial infarction.